Grove Biopharma, Inc. | Company Profile
Grove Biopharma, Inc.
Overview
Grove Biopharma, Inc. is a biotechnology company based in Chicago that focuses on developing innovative therapeutics using its proprietary Bionic Biologicsβ’ platform. This platform combines biologic and synthetic design principles to target intracellular protein-protein interactions, which are often challenging for existing therapies. The company aims to create new treatments for chronic inflammatory and neurodegenerative diseases, as well as other serious conditions.
Founded as a spinout from Northwestern University, Grove Biopharma brings together a diverse team of experts, including chemists, biologists, and materials scientists. Demonstrating proof-of-concept for its synthetic biologics, the company engineers solutions to penetrate cells and modulate hard-to-reach intracellular targets. Grove Biopharma has secured substantial investment, including a $30 million Series A round, emphasizing its strong position in the biotechnology and pharmaceutical industries.
Basic Information
Industry | research |
---|---|
Founded | 2020 |
Revenue | |
Headquarters | 1375 W Fulton St, Chicago, Illinois, 60607-1128, United States |
Alexa Ranking |
Contact Details
- Phone: +1 847-431-7211
- Website: grovebiopharma.com
- LinkedIn: linkedin.com/company/grove-biopharma-inc
Key Focus Areas & Initiatives
- Biotechnology research
- Pharmaceuticals
- Peptide inputs
- Targeted biologics
- Biotech innovation
- Target engagement
- Drug discovery
- Degraders
- Therapeutics
- Synthetic biologics
- Disrupt protein interactions
- Protein-protein interactions
- Biologics
- Cell-penetrant biologics
- Polymerization process
- First-in-class drugs
- Pharmacology
- Modular design
- Cell permeable
- Synthetic biologic platform
- Synthetic chemistry
- Structural biology
- Target-agnostic platform
- Drug development
- Modular biologics
- Amphiphilic architecture
- Intracellular targets
- Bionic biologics
- Preclinical models
- Medical research
- Globular morphology
- Cancer targets
- Long half-life
- Protein-scale molecules
- Neurodegenerative diseases
- Bionic architecture
- Precision polymerization
- Disruptor molecules
- AI/ML design
- Modular assembly
- Biotechnology
- Target-agnostic
- Proteomimetics
- Protein mimetics
- B2B
- Research and development in the physical, engineering, and life sciences
- Oncology
- Medical
- Hospital & health care
Technologies Used
- Amazon AWS
- Android
- Domo
- Google Font API
- Microsoft Office 365
- Mobile Friendly
- Nginx
- Outlook
- Sisense
- Splunk
- WordPress.org
Affiliated Organizations & Regional Branches
Need more information?
Find decision makers, more insights and contact information about this company on Bitscale
Try Bitscale Now